Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Doherty, Kathleen ^a   Essajee, Shaffiq ^b,c   Penazzato, Martina ^d   Holmes, Charles ^e   Resch, Stephen ^f   Ciaranello, Andrea ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLINTON HEALTH ACCESS INITIATIVE   (United States)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antiretroviral therapy; Costs; Pediatric HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; BODY WEIGHT; CHILD; COST; DOSE CALCULATION; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE PLANNING; HIV INFECTIONS; HUMAN; INFANT; MALE; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTI-HIV AGENTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; DRUG COSTS; DRUG DOSAGE CALCULATIONS; FEMALE; GUIDELINES AS TOPIC; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; WORLD HEALTH ORGANIZATION;

EID: 84900416002     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-201     Document Type: Article

References (39)

1. Progress Report 2011: Global HIV/AIDS response: epidemic update and health sector progress towards universal access. World Health Organization, [ http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/ gr2012/20121120-UNAIDS-Global-Report-2012-with-annexes-en.pdf ] Accessed October 16, 2013
2. Early antiretroviral therapy and mortality among HIV-infected infants. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA, N Engl J Med 2008 359 21 2233 2244 10.1056/NEJMoa0800971 19020325
3. Report on the Global AIDS Epidemic. UNAIDS, [ http://www.unaids.org/en/ media/unaids/contentassets/documents/epidemiology/2012/gr2012/ 20121120-UNAIDS-Global-Report-2012-en.pdf ] Accessed October 7, 2013
4. U.S. Global Health Policy. The Henry J. Kaiser Family Foundation, [ http://www.kff.org/globalhealth/upload/8002-04.pdf ] Accessed October 25, 2012
5. THLBB103: The Cost of Early vs. Deferred Paediatric Antiretroviral Treatment in South Africa-a Comparative Economic Analysis of the First Year of the CHER Trial. Meyer-Rath G, Violari A, Cotton M, Ndibongo B, Brenna A, Long L, Panchia R, Coovadia A, Gibb DM, Rosen S, International AIDS society: 2010 Vienna, Austria: 2010
6. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. Schneider K, Puthanakit T, Kerr S, Law MG, Cooper DA, Donovan B, Phanuphak N, Sirisanthana V, Ananworanich J, Ohata J, Wilson DP, AIDS 2011 25 9 1143 1151 10.1097/QAD.0b013e3283466fab 21505319
7. Antiretroviral Therapy for HIV Infection in Infants and Children: Recommendations for a Public Health Approach. World Health Organization, [ http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html ] Accessed October 18, 2013
8. First-line ART regimens for HIV-infected children: A model-based cost-effectiveness analysis. Ciaranello A, Babiker A, Doherty K, Essajee K, Freedberg K, Gibb D, Harrison L, Hou T, Lindsey J, Losina E, Muhe L, Palumbo P, Penazzato M, Walensky R, Weinstein MC, World Health Organization Maternal and Child Health Guidelines Development Group Meeting: December 11-13, 2012; Geneva, Switzerland 2012
9. Antiretroviral treatment for children with peripartum nevirapine exposure. Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Violari A, N Engl J Med 2010 363 16 1510 1520 10.1056/NEJMoa1000931 20942667
10. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, Millar L, Petzold E, Mofenson LM, Jean-Philippe P, Palumbo P, N Engl J Med 2012 366 25 2380 2389 10.1056/NEJMoa1113249 22716976
11. ARROW Trial. Anti-Retroviral Research for Watoto, [ http://www. arrowtrial.org/default.asp ] Accessed November 1, 2013
12. Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial. Paediatric European Network for Treatment of AIDS (PENTA), Lancet 2002 359 9308 733 740 11888583
13. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. O'Brien DP, Sauvageot D, Zachariah R, Humblet P, AIDS 2006 20 15 1955 1960 10.1097/01.aids.0000247117.66585.ce 16988517
14. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. Vanprapar N, Cressey TR, Chokephaibulkit K, Muresan P, Plipat N, Sirisanthana V, Prasitsuebsai W, Hongsiriwan S, Chotpitayasunondh T, Eksaengsri A, Toye M, Smith ME, McIntosh K, Capparelli E, Yogev R, IMPAACT P1056 Team, Pediatr Infect Dis J 2010 29 10 940 944 10.1097/INF.0b013e3181e2189d 20453709
15. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children. Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, Yogev R, IMPAACT P1069 Team, Antivir Ther 2011 16 8 1287 1295 10.3851/IMP1931 22155910
16. WHO Paediatric Working Group, Interagency Task Team on Prevention and Treatment of HIV Infection in Pregnant Women, Mothers and Their Children: Developing an Optimized List of Paediatric ARV Formulations Geneva, Switzerland: World Health Organization 2011
17. Antiretroviral drug dosing chart for children. South African National Department of Health, Southern African HIV Clinicians Society, [ http://www.sahivsoc.org/upload/documents/ 2012%20ARV%20Dosing%20Chart%20for%20Children%20and%20Adolescents.pdf ] Accessed April 10, 2013
18. The South African Antiretroviral Treatment Guidelines. Department of Health Republic of South Africa, [ http://www.uj.ac.za/EN/CorporateServices/ ioha/Documentation/Documents/ART%20Guideline.pdf ] Accessed April 10, 2013
19. Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges. Phelps BR, Rakhmanina N, Paediatr Drugs 2011 13 3 175 192 10.2165/11587300-000000000-00000 21500872
20. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. TREAT Asia Pediatric HIV Observational Database (TApHOD), J Int AIDS Soc 2011 14 7 21306608
21. Guidelines for the use of Antiretroviral Agents in Pediatric HIV Infection. Department of Health and Human Services. Panel on Antiretroviral Therapy and Medication of HIV-Infected Children, [ http://aidsinfo.nih.gov/ contentfiles/lvguidelines/pediatricguidelines.pdf ] Accessed September 2, 2013
22. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs. Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM, AIDS 2011 25 14 1753 1760 10.1097/QAD.0b013e3283463eec 21412127
23. Cost and outcomes of paediatric antiretroviral treatment in South Africa. Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, Fairlie L, Coovadia A, Rosen S, AIDS 2013 27 2 243 250 10.1097/QAD.0b013e32835a5b92 23014517
24. Antiretroviral (ARV) Ceiling Price List. Clinton Health Access Initiative, [ http://d2pd3b5abq75bb.cloudfront.net/2012/07/12/15/03/07/163/CHAI- ARV-Ceiling-Price-List-May-2012.pdf ] Accessed October 14, 2013
25. Untangling the web of Antiretroviral Price Reductions: 15th Edition. Médecins Sans Frontières, [ http://aids2012.msf.org/wp-content/ uploads/2012/07/MSF-Access-UTW-15th-Edition-2012-webres.pdf ] Accessed April 10, 2013
26. ARV Tenders Mean More can now Access Treatment. Heath-e, [ http://www.health-e.org.za/2010/12/15/arv-tenders-mean-more-can-now-access- treatment/ ] Accessed April 10, 2013
27. PAHO lauds 10 Latin American countries for negotiating discounts for HIV drugs. United Nations, [ http://www.un.org/apps/news/story.asp?NewsID= 7416&Cr=hiv&Cr1=aids ] Accessed May 6, 2014
28. Consolidated Guidelines on the use of Antiretrovirals for the Treatment and Prevention of HIV Infection. World Health Organization, [ http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html ] Accessed October 20, 2013
29. Approved and Tentatively Approved Antiretrovirals in Association with the President's Emergency Plan. President's Emergency Plan for AIDS Relief (PEPFAR), [ http://www.fda.gov/InternationalPrograms/ FDABeyondOurBordersForeignOffices/AsiaandAfrica/ucm119231.htm ] Accessed February 7, 2013
30. WHO Child Growth Standards: Length/Height-for-age, Weight-for-age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-age: Methods and Development. World Health Organization Multicentre Growth Reference Study Group, [ http://www.who.int/childgrowth/standards/technical-report/en/index.html ] Accessed October 19, 2013
31. Data Table of Weight-for-age Charts. Center for Disease Control and Prevention (CDC), [ http://www.cdc.gov/growthcharts/html-charts/wtage.htm ] Accessed December 21, 2012
32. The LMS method for constructing normalized growth standards. Cole TJ, Eur J Clin Nutr 1990 44 1 45 60
33. Effectiveness of pediatric ART in resource-limited settings: a systematic review and meta-analysis. Ciaranello A, Chang Y, Margulis A, Bernstein A, Bassett IV, Losina E, Walensky RP, Clin Infect Dis 2009 49 12 1915 1927 10.1086/648079 19916798
34. Percentile Data Files with LMS Values. Center for Disease Control and Prevention (CDC), [ http://www.cdc.gov/growthcharts/percentile-data-files.htm ] Accessed June 6, 2013
35. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. European Paediatric Lipodystrophy Group, AIDS 2004 18 10 1443 1451 15199321
36. Global Price Reporting Mechanism for HIV, Tuberculosis and Malaria. World Health Organization, [ http://www.who.int/hiv/amds/gprm/en/ ] Accessed December 26, 2012
37. Addressing the Drug Development Needs of Infants and Young Children: DNDi's Pediatric HIV Program. Chang S, 19th Interational AIDS Conference: July 22, 2012 2012; Washington, D.C 2012
38. Progress Report 2011: Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access. World Health Organization, [ http://www.who.int/hiv/pub/progress-report2011/en/index.html ] Accessed January 20, 2013
39. Treatment of young children with HIV infection: using evidence to inform policymakers. Prendergast AJ, Penazzato M, Cotton M, Musoke P, Mulenga V, Abrams EJ, Gibb DM, PLoS Med 2012 9 7 1001273 10.1371/journal.pmed.1001273 22910874